Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04415944 · ClinicalTrials.gov registry record · Phase 2
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT04415944 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.
The verdict
NCT04415944, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if it is feasible to receive heated chemotherapy or heated intraperitoneal chemotherapy (HIPEC) inserted directly into the abdomen at the time of a Second Look Reassessment Surgery and to monitor any effects good or bad that this has on participants' health.
Interventions
- PROCEDURE Second look laparoscopy reassessment surgery (SLLRS)
- DRUG HIPEC with Carboplatin
- OTHER FACT-O Quality of Life Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-05-20 |
| Est. Completion | 2026-01-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04415944
The ClinicalTrials.gov registry entry for NCT04415944 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Second look laparoscopy reassessment surgery (SLLRS) is the first listed.
NCT04415944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04415944 about?
NCT04415944 is a clinical study titled "Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy". The purpose of this research study is to see if it is feasible to receive heated chemotherapy or heated intraperitoneal chemotherapy (HIPEC) inserted directly into the abdomen at the time of a Second Look Reassessment Surgery and to monitor any effects good or bad that this has on participants' heal...
What is the current status of trial NCT04415944?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2021-05-20. Estimated completion is 2026-01-23.
What interventions are being tested in trial NCT04415944?
The interventions under investigation include: Second look laparoscopy reassessment surgery (SLLRS) (PROCEDURE), HIPEC with Carboplatin (DRUG), FACT-O Quality of Life Questionnaire (OTHER).
Who is sponsoring clinical trial NCT04415944?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.